-+ 0.00%
-+ 0.00%
-+ 0.00%

*Agenus Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer

Dow Jones·08/06/2026 11:34:00

Please log in to view news